FDA: Safety Labeling Changes Made to Prescribing Information for 48 Products in November

The U.S. Food and Drug Administration has published safety labeling changes made prescribing information for 48 products in November.

Advertisement

 

Changes were made to boxed warnings, contraindications, warnings, precautions, adverse reactions, patient package insert and medication guide.

 

The following drugs had modifications to the boxed warnings, contraindications and warnings sections:

  • Cerebyx (fosphenytoin sodium)
  • Dilantin (phenytoin sodium, USP)
  • Dilantin (phenytoin)
  • Kombiglyze XR (saxagliptin/metformin hydrochloride extended-release)
  • Mytelase (ambenonium chloride)
  • Onglyza (saxagliptin)
  • Amturnide (aliskiren/amlodipine/hydrochlorothiazide)
  • Combivir (lamivudine/zidovudine)
  • Emtriva (emtricitabine)
  • Epivir (lamivudine)
  • Epzicom (abacavir sulfate and lamivudine)
  • Isentress (raltegravir potassium)
  • Lioresal Intrathecal (baclofen injection)
  • Methotrexate Sodium for Injection
  • Retrovir (zidovudine)
  • Tekamlo (aliskiren/amlodipine)
  • Toviaz (fesoterodine fumarate)
  • Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide)
  • Trizivir (abacavir sulfate, lamivudine, and zidovudine)
  • Twynsta (telmisartan/amlodipine)
  • VFEND (voriconazole)
  • Videx (didanosine)
  • Videx EC (didanosine, USP)
  • Vimovo (naproxen/esomeprazole magnesium)
  • Viread (tenofovir disoproxil fumarate)
  • Zerit (stavudine)
  • Ziagen (abacavir sulfate)
  • Zyflo CR (zileuton)

 

To view a listing of drug names and safety labeling sections revised, click here. Clicking on a drug product name in the Summary View will take you to the “detailed view” page, which identifies safety labeling sections and subsections revised, along with a brief summary of new or modified safety information.

 

Related Articles on Medication Safety:

CMS Issues Revised ’30-Minute Rule’ on Administration of Medication

Patient Education Tool: 10 Tips to Prevent Accidental Medicine Overdose

11 Strategies to Address Physician and Staff Resistance to Complying With Infection Control Guidelines

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Accreditation, Licensure & Medicare Certification

  • Atlanta-based United Digestive is planning an ASC in Watkinsville, Ga., focusing on organic growth to expand its network. The newly-constructed,…

  • At least 25 ASCs have closed over the past five years, a pattern of attrition driven by financial strain, staffing…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

Advertisement

Comments are closed.